B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma.
Saved in:
| Title: | B Cell dysfunction in tumor-draining lymph nodes predicts relapse in oral squamous cell carcinoma. |
|---|---|
| Authors: | Liljeström V; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Farrajota Neves da Silva P; Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Bark R; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Elliot A; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Marklund L; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden.; Department of Surgical Sciences, Section of Otolaryngology and Head and Neck Surgery, Uppsala University, Uppsala, Sweden., Margolin G; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Medical Unit Head Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Kumlien Georén S; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden., Cardell LO; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden., Piersiala K; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. krzysztof.piersiala@ki.se.; Department of Otorhinolaryngology, Karolinska University Hospital, Stockholm, Sweden. krzysztof.piersiala@ki.se. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Nov 12; Vol. 74 (12), pp. 373. Date of Electronic Publication: 2025 Nov 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
